Epidemiology: Open Access
Open Access

Emerging infectious diseases; Epidemiology; Public health; Surveillance; Microbial adaptation; Global health

Introduction

Emerging infectious diseases (EIDs) are defined as infections that have recently appeared within a population or those whose incidence or geographic range is rapidly increasing or threatens to increase in the near future. The last few decades have seen the emergence of diseases such as HIV/AIDS, SARS, MERS, Ebola, Zika, and COVID-19, underscoring the continuous threat EIDs pose to global health, economies, and security. The epidemiology of infectious diseases is an essential field of study that provides insights into the distribution, determinants, and deterrents of diseases, playing a crucial role in the development of effective public health strategies. This article delves into the trends observed in the emergence of infectious diseases and the challenges faced by epidemiologists and public health professionals [1].

Emerging infectious diseases (EIDs)

The emergence of new pathogens and the re-emergence of previously controlled diseases highlight the dynamic and evolving nature of infectious disease epidemiology.

Historical context: Throughout history, humanity has faced numerous pandemics and epidemics, from the Black Death in the 14th century to the Spanish flu in the early 20th century. However, the acceleration of globalization, urbanization, and environmental changes in recent decades has facilitated the rapid spread of infectious agents, leading to the emergence of novel diseases and the resurgence of existing ones [2].

Factors contributing to emergence: The emergence and spread of EIDs are influenced by a complex interplay of factors, including:

Environmental changes: Deforestation, climate change, and alterations in ecosystems can disrupt natural balances, leading to increased human-wildlife interactions and the potential for zoonotic disease spillover.

Globalization and travel: Modern transportation networks allow pathogens to traverse geographical barriers swiftly, making containment and control efforts more challenging [3].

Antimicrobial resistance (AMR): Overuse and misuse of antibiotics and antimicrobial agents have contributed to the development of drug-resistant pathogens, reducing treatment options and increasing the risk of treatment failure.

Urbanization: Rapid urbanization, particularly in low- and middle-income countries, can create crowded living conditions, inadequate sanitation, and limited access to healthcare, fostering the transmission of infectious diseases.

Notable EIDs: In recent decades, several notable EIDs have emerged, including:

HIV/AIDS: The human immunodeficiency virus (HIV) emerged in the late 20th century, leading to a global pandemic with profound social, economic, and health consequences.

SARS and MERS: Severe Acute Respiratory Syndrome (SARS) and Middle East Respiratory Syndrome (MERS) were caused by novel coronaviruses, highlighting the potential for zoonotic spillover and rapid human-to-human transmission.

Ebola virus disease: Outbreaks of Ebola in Africa have demonstrated the devastating impact of highly virulent pathogens and the challenges of outbreak control in resource-limited settings.

Zika virus: The Zika virus outbreak raised concerns about congenital abnormalities and neurological complications, prompting global public health responses.

Public health response: The management of EIDs requires a multifaceted public health response that includes:

Surveillance and early detection: Robust surveillance systems are essential for early detection, rapid response, and the implementation of containment measures.

Risk communication: Transparent and timely communication with the public, healthcare providers, and policymakers is critical for maintaining trust, disseminating accurate information, and promoting preventive behaviors [4].

Research and innovation: Continued research into pathogen biology, transmission dynamics, and vaccine development is essential for preparedness and response efforts.

In light of ongoing challenges such as the COVID-19 pandemic, antimicrobial resistance, and the potential for future EIDs, understanding the epidemiology of infectious diseases and implementing evidence-based interventions are paramount to safeguarding global health security and resilience [5].

Discussion

Trends in emerging infectious diseases

The incidence of EIDs has been on the rise, fueled by factors such as urbanization, environmental degradation, climate change, increased interaction between humans, wildlife and globalization [6]. Technological advancements and global travel have facilitated the rapid spread of pathogens across continents, exemplified by the 2019 novel coronavirus (COVID-19) pandemic. Additionally, antimicrobial resistance has emerged as a formidable challenge, complicating the treatment of infectious diseases and leading to increased mortality and morbidity.

Challenges in epidemiology

Epidemiologists face several challenges in managing EIDs, including the rapid identification of new pathogens, understanding their transmission dynamics, and developing effective control strategies. Limited resources, inadequate surveillance systems, and the need for timely data sharing between countries add to the complexity of controlling EIDs. Furthermore, socio-political factors often influence the implementation of public health interventions, necessitating a multidisciplinary approach that includes political, social, and ecological considerations.

Advancements and strategies for improvement

Recent advancements in genomics, bioinformatics, and data analytics have enhanced the ability to detect and track EIDs. The integration of digital health technologies, such as mobile health apps and electronic health records, into surveillance systems has improved real-time monitoring and response capabilities. However, there is a critical need to strengthen global partnerships, enhance the capacity of public health systems in low-resource settings, and foster a one Health approach that recognizes the interconnection between human, animal and environmental health [7].

Conclusion

Emerging infectious diseases remain a formidable challenge to global health, necessitating continuous vigilance, research, and innovation in epidemiology and public health practice. While advancements in technology and data analytics offer new tools for disease surveillance and control, the successful management of EIDs requires a coordinated, multidisciplinary approach that addresses the underlying socio-economic and environmental factors contributing to their emergence. Strengthening global health security, improving surveillance and response systems, and investing in public health infrastructure and research are imperative to mitigate the impact of future outbreaks and protect global health.

Acknowledgement

None

Conflict of Interest

None

References

1. McArthur DB (2019) Emerging Infectious Diseases. Nurs Clin North Am 54: 297-311.

Indexed at, Google Scholar, CrossRef

2. Hao R, Liu Y, Shen W, Zhao R, Jiang B, et al. (2022) Surveillance of emerging infectious diseases for biosecurity. Sci China Life Sci 65: 1504-1516.

Indexed at, Google Scholar, CrossRef

3. Jones KE, Patel NG, Levy MA, Storeygard A, Balk D, et al. (2008) Global trends in emerging infectious diseases. Nature 451: 990-993.

Indexed at, Google Scholar, CrossRef

4. McAnulty JM (2016) Emerging infectious diseases. Public Health Res Pract 26: 2651653.

Indexed at, CrossRef

5. Jiang S, Hotez PJ (2015) Combating the emerging viral infectious diseases. Microbes Infect 17: 83.

Indexed at, Google Scholar, CrossRef

6. Nii-Trebi NI (2017) Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges. Biomed Res Int 2017: 5245021.

Indexed at, Google Scholar, CrossRef

7. Cunningham AA, Daszak P, Wood JLN (2017) One Health, emerging infectious diseases and wildlife: two decades of progress?. Philos Trans R Soc Lond B Biol Sci 372: 20160167.

Indexed at, Google Scholar, CrossRef